Stocks › AVAH
Aveanna Healthcare Holdings Inc (AVAH) stock analysis
WEAK BUY 14% confidence · analysed Aug 10, 2026
This analysis is from Aug 10, 2026 and may be out of date.
On Aug 10, 2026, our model rated Aveanna Healthcare Holdings Inc (AVAH) WEAK BUY with 14% confidence at a price of $9.60. That means the signals lean positive, but they are mixed, so conviction is low.
Fundamentals
In its latest quarter it earned $0.18 per share, which beat the $0.13 analysts expected, with revenue +15.9% year over year.
The next earnings report is expected around Aug 13, 2026; prices often move sharply around earnings.
Research notes
AVAH’s bull case is that analysts remain constructive: the stock has a Moderate Buy/Buy consensus, with average 12-month targets around $10.45–$10.61 versus a recent price near $9.49, implying modest upside. Supporters also point to healthy fundamentals, high institutional ownership, and expectations for mid-term upward trend** and improved execution.
The bear case is that near-term technicals are mixed, with one screen showing neutral-to-sell signals and weak momentum indicators, suggesting the stock may be range-bound rather than trending strongly higher. The stock also still faces normal execution risk in a healthcare-services business, and the analyst target spread runs from $8 to $13**, showing meaningful disagreement on valuation and outlook.
The key recent catalyst is the market’s attention on upcoming Q2 2026 earnings expected around August 13, which investors are using to judge integration progress, margin trends, and whether management can support raised guidance after the Family First Homecare acquisition. Recent brokerage coverage also reinforced the constructive view, with MarketBeat reporting a Moderate Buy consensus on August 6.
The model's one-paragraph read
Leans BUY — composite score +0.14 (WEAK BUY). Technicals: RSI 46.32, MACD bearish, price above SMA50. Fundamentals: margin 10.4%, revenue growth 15.9%. Financial results: YoY revenue +15.9%, last EPS surprise +38.5%, next earnings 2026-08-13. FinGPT news read: neutral. Internet research: **AVAH’s bull case** is that analysts remain constructive: the stock has a **Moderate Buy/Buy** consensus, with average 12-month targets around **$10.45–$10.61** versus a recent price near **$9.49**, implying modest upside. Supporters also point to **healthy fundamentals**, **high institutional ownership**, and expectations for **mid-term upward trend** and improved execution. **The bear case** is that near-term technicals are mixed, with one screen showing **neutral-to-sell** signals and weak momentum indicators, suggesting the stock may be range-bound rather than trending strongly higher. The stock also still faces normal execution risk in a healthcare-services business, and the analyst target spread runs from **$8 to $13**, showing meaningful disagreement on valuation and outlook. The key **recent catalyst** is the market’s attention on **upcoming Q2 2026 earnings expected around August 13**, which investors are using to judge integration progress, margin trends, and whether management can support raised guidance after the Family First Homecare acquisition. Recent brokerage coverage also reinforced the constructive view, with MarketBeat reporting a **Moderate Buy** consensus on August 6.
Past ratings for AVAH
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Aug 10, 2026 | WEAK BUY | 14% | $9.60 | — |
"Move since" compares each call's price with the latest analysed price.
Other Healthcare stocks we cover
BCRX · BDX · BIIB · BMY · BSX · CMPS · CNC · COO · CRL · CVS · CYTK · DVA
Frequently asked questions
Is AVAH a buy right now?
As of Aug 10, 2026, our automated model rates Aveanna Healthcare Holdings Inc (AVAH) WEAK BUY with 14% confidence: the signals lean positive, but they are mixed, so conviction is low. This is a model output for education, not personal investment advice.
When does Aveanna Healthcare Holdings Inc report earnings next?
The next earnings report is expected around Aug 13, 2026.
What does a WEAK BUY rating mean?
A WEAK BUY rating means the signals lean positive, but they are mixed, so conviction is low.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.